Free radical theory of aging: Alzheimer’s disease pathogenesis

Senile dementia of the Alzheimer’s type (SDAT) is the major cause of dementia. SDAT cases can be categorized into two groups: 1) late onset, after about age 60, 90–95 percent of cases; largely nonfamilial, i.e., sporadic, 2) early onset, before about age 60; 5–10 percent of cases, most — if not all — are familial. It is a systemic disorder whose major manifestations are in the brain. The brain lesions in both early and late-onset SDAT are the same as those seen in smaller numbers in normal older individuals.It is hypothesized that SDAT is caused by increased free radical reaction levels in brain neurons that advance in time patterns of neuronal dysfunction and cell loss. Measures to this end include: 1) mutations in mitochondrial (mt) DNA and/or nuclear (nuc) DNA in a somatic cell early in development that adversely effect mitochondrial function, 2) mutations in maternal mtDNA and/or nucDNA that impair mitochondria in offspring, 3) mutations in the amyloid precursor protein (APP), and 4) increased formation of both normal APP and superoxide dismutase (SOD).The incidence of SDAT may be decreased by efforts to minimize free radical reactions involved in initiation. The clinical decline of SDAT patients may be slowed by measures which lower the level of more-or-less random deleterious free radical reactions.

[1]  C. Duyckaerts,et al.  Large amounts of neocortical βA4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person , 1990, Neuroscience Letters.

[2]  S. Younkin,et al.  Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. , 1993, Science.

[3]  G K Wilcock,et al.  Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[4]  G. V. Van Hoesen,et al.  Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. , 1984, Science.

[5]  M. L. Schmidt,et al.  An extensive network of PHFτ‐rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease , 1994, FEBS letters.

[6]  Robert Hill,et al.  Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease , 1995, Annals of neurology.

[7]  S. Prusiner,et al.  Molecular biology of prion diseases , 1991, Science.

[8]  M. Mattson,et al.  β-Amyloid Peptide Free Radical Fragments Initiate Synaptosomal Lipoperoxidation in a Sequence-Specific Fashion: Implications to Alzheimer′s Disease , 1994 .

[9]  P. Moran,et al.  Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Selkoe,et al.  Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.

[11]  Carl W. Cotman,et al.  Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  D. Melton,et al.  Vertebrate embryonic induction: mesodermal and neural patterning. , 1994, Science.

[13]  R. Godwin-Austen,et al.  DIFFUSE LEWY BODY DISEASE: AN IMPORTANT DIFFERENTIAL DIAGNOSIS IN DEMENTIA WITH EXTRAPYRAMIDAL FEATURES , 1989, Progress in clinical and biological research.

[14]  N Butters,et al.  Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia. , 1994, Archives of neurology.

[15]  D. Hegner,et al.  Mitochondrial formation of OH Radicals by an ubisemiquinone-dependent reaction an alternative pathway to the iron-catalysed Haber-Weiss cycle. , 1982, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[16]  B. Chance,et al.  31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Orrenius,et al.  Role of calcium in toxic and programmed cell death. , 1991, Advances in experimental medicine and biology.

[18]  A. Scheibel,et al.  A Reexamination of Aluminum in Alzheimer's Disease: Analysis by Energy Dispersive X-ray Microprobe and Flameless Atomic Absorption Spectrophotometry , 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[19]  M. Mesulam,et al.  β-Amyloid and the pathogenesis of alzheimer's disease , 1991 .

[20]  S. Orrenius,et al.  Role of Ca2+ in toxic cell killing. , 1989, Trends in pharmacological sciences.

[21]  T. Ozawa,et al.  Age-associated damage in mitochondrial DNA in human hearts , 1993, Molecular and Cellular Biochemistry.

[22]  C. Behl,et al.  Amyloid peptides are toxic via a common oxidative mechanism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Behl,et al.  Hydrogen peroxide mediates amyloid β protein toxicity , 1994, Cell.

[24]  Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[25]  T. Molitor,et al.  Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. , 1992, Journal of immunology.

[26]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[27]  J. Ordy,et al.  Free radical theory of aging: Effect of dietary lipids on lipofuscin accumulation in the hippocampus of rats , 2006, AGE.

[28]  R. Katzman.,et al.  Advances in Alzheimer's disease , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  D. Neary,et al.  Metabolic Processes in Alzheimer's Disease: Adenine Nucleotide Content and Production of 14CO2 from [U‐14C]Glucose In Vitro in Human Neocortex , 1983, Journal of neurochemistry.

[30]  C. Cotman,et al.  Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Martins,et al.  Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. , 1989, The New England journal of medicine.

[32]  L. Rowland Mitochondrial encephalomyopathies: lumping, splitting and melding , 1994 .

[33]  J. Bogaard,et al.  NADH-CoQ REDUCTASE DEFICIENT MYOPATHY: SUCCESSFUL TREATMENT WITH RIBOFLAVIN , 1983, The Lancet.

[34]  K. Miyoshi,et al.  Degeneration of neuronal processes in rats induced by a protease inhibitor, leupeptin , 2004, Acta Neuropathologica.

[35]  J. Hickman,et al.  Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. , 1993, The EMBO journal.

[36]  P. Mantyh,et al.  Aluminum, Iron, and Zinc Ions Promote Aggregation of Physiological Concentrations of β‐Amyloid Peptide , 1993, Journal of neurochemistry.

[37]  K. Davis,et al.  Age-dependent expression of familial risk in Alzheimer's disease. , 1988, American journal of epidemiology.

[38]  C. Cotman,et al.  Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. , 1992, The Journal of biological chemistry.

[39]  David M. A. Mann,et al.  The neuropathology of Alzheimer's disease: A review with pathogenetic, aetiological and therapeutic considerations , 1985, Mechanisms of Ageing and Development.

[40]  Z. Oltvai,et al.  Bcl-2 functions in an antioxidant pathway to prevent apoptosis , 1993, Cell.

[41]  J. M. Anderson,et al.  SEX DIFFERENCES IN AGE-RELATED BRAIN ATROPHY , 1983, The Lancet.

[42]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[43]  J. Cleveland,et al.  Contenders in FasL/TNF death signaling , 1995, Cell.

[44]  R. S. Sohal,et al.  Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse , 1994, Mechanisms of Ageing and Development.

[45]  R. Nixon,et al.  Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Landin,et al.  Ultrastructure of skeletal muscle in patients with Parkinson's disease and upper motor lesions. , 1975, Laboratory investigation; a journal of technical methods and pathology.

[47]  D. Ferrari,et al.  Activation of microglial cells by β-amyloid protein and interferon-γ , 1995, Nature.

[48]  F. Zemlan,et al.  Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation , 1989, Brain Research.

[49]  B. Hyman,et al.  Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions , 1993, Neuron.

[50]  V. Meininger,et al.  A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. , 1994, The New England journal of medicine.

[51]  L. Isenman,et al.  Secretion of intact proteins and peptide fragments by lysosomal pathways of protein degradation. , 1989, The Journal of biological chemistry.

[52]  A. Roses,et al.  Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. , 1994, The Journal of clinical investigation.

[53]  R. Sutton,et al.  β-BLOCKERS, AUTOIMMUNITY, AND RASHES , 1980, The Lancet.

[54]  M. Mattson,et al.  A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[55]  S. Younkin Evidence that Aβ42 is the real culprit in alzheimer's disease , 1995 .

[56]  G WhittakerP,et al.  共やくエクイン・エストロゲン(Premarin)服用閉経婦人の血清エクイリン,エストロン,エストラジオール値 , 1980 .

[57]  F. Tagliavini,et al.  Alzheimer patients and Down patients: Cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques , 1989, Neuroscience Letters.

[58]  T. Molitor,et al.  Neuroprotective role of IL-4 against activated microglia. , 1993, Journal of immunology.

[59]  E. Stopa,et al.  Expression of heme oxygenase‐1 in the senescent and alzheimer‐diseased brain , 1995, Annals of neurology.

[60]  E. Janzen A Critical Review of Spin Trapping in Biological Systems , 1980 .

[61]  D. Wallace,et al.  Oxidative Phosphorylation Diseases , 1990 .

[62]  E. Masliah,et al.  Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease , 1989, Neuroscience Letters.

[63]  N. Khansari,et al.  Immunological dysfunction in Alzheimer's disease , 1985, Journal of Neuroimmunology.

[64]  Sangkot Marzuki,et al.  MITOCHONDRIAL DNA MUTATIONS AS AN IMPORTANT CONTRIBUTOR TO AGEING AND DEGENERATIVE DISEASES , 1989, The Lancet.

[65]  E. Stadtman Protein oxidation and aging. , 1992, Free radical research.

[66]  E. Masliah,et al.  Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. , 1990, The American journal of pathology.

[67]  H. Wiśniewski,et al.  Morphology of the aging brain, human and animal. , 1973, Progress in brain research.

[68]  J. Weber,et al.  Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. , 1992, Science.

[69]  S. Yamashita,et al.  Mitochondrial DNA and human thyroid diseases. , 2004, Endocrine journal.

[70]  J. Reed,et al.  Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease , 1991 .

[71]  T D Koepsell,et al.  The association between head trauma and Alzheimer's disease. , 1990, American journal of epidemiology.

[72]  E. Mandelkow,et al.  The Alzheimer‐like phosphorylation of tau protein reduces microtubule binding and involves Ser‐Pro and Thr‐Pro motifs , 1992, FEBS letters.

[73]  H. Wiśniewski,et al.  EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION: 1. LIGHT MICROSCOPIC OBSERVATIONS , 1965, Journal of neuropathology and experimental neurology.

[74]  M. Pericak-Vance,et al.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[75]  E M Wijsman,et al.  A familial Alzheimer's disease locus on chromosome 1 , 1995, Science.

[76]  C. Barrow,et al.  Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. , 1991, Science.

[77]  Denham Harman,et al.  The Biologic Clock: The Mitochondria? , 1972, Journal of the American Geriatrics Society.

[78]  T. Ozawa,et al.  Hypothesis. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases , 1989 .

[79]  K. Kosik,et al.  Neuritic pathology and dementia in alzheimer's disease , 1991, Annals of neurology.

[80]  G. Schellenberg,et al.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.

[81]  S. Hirai,et al.  Ultrastructure of diffuse plaques in senile dementia of the Alzheimer type: comparison with primitive plaques , 2004, Acta Neuropathologica.

[82]  H. Braak,et al.  Cognitive impairment in Parkinson's disease: amyloid plaques, neurofibrillary tangles, and neuropil threads in the cerebral cortex , 1990, Journal of neural transmission. Parkinson's disease and dementia section.

[83]  K. Ikeda,et al.  Synthetic Alzheimer amyloid β/A4 peptides enhance production of complement C3 component by cultured microglial cells , 1993, Brain Research.

[84]  D. Wallace Mitochondrial genetics: a paradigm for aging and degenerative diseases? , 1992, Science.

[85]  D. Johns Seminars in medicine of the Beth Israel Hospital, Boston. Mitochondrial DNA and disease. , 1995, The New England journal of medicine.

[86]  P. Frost,et al.  Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease. , 1992, Age and ageing.

[87]  Edward Byrne,et al.  DECLINE IN SKELETAL MUSCLE MITOCHONDRIAL RESPIRATORY CHAIN FUNCTION: POSSIBLE FACTOR IN AGEING , 1989, The Lancet.

[88]  S. Dimauro,et al.  Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. , 1989, The New England journal of medicine.

[89]  J. Coyle,et al.  Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.

[90]  S. Lipton,et al.  Excitatory amino acids as a final common pathway for neurologic disorders. , 1994, The New England journal of medicine.

[91]  Y. Wei,et al.  Liver mitochondrial respiratory functions decline with age. , 1989, Biochemical and biophysical research communications.

[92]  J. Connor,et al.  Aluminum access to the brain: a role for transferrin and its receptor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[93]  M J Ball,et al.  Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. , 1993, The Journal of biological chemistry.

[94]  D. Shibata,et al.  A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[95]  V. Yong,et al.  Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease , 1987, Annals of neurology.

[96]  D. Mann,et al.  Is the "preamyloid" of diffuse plaques in Alzheimer's disease really nonfibrillar? , 1993, The American journal of pathology.

[97]  M. Waldrop New Light on Dark Matter?: It fills the universe, it is utterly invisible, and it may not even exist; meanwhile, the hypotheses are getting more exotic. , 1984, Science.

[98]  J Lejeune,et al.  Trisomy 21 (Down's syndrome). Glutathione peroxidase, hexose monophoshate shunt and I.Q. , 1979, Life sciences.

[99]  G. Lynch,et al.  Inhibitors of lysosomal enzymes: accumulation of lipofuscin-like dense bodies in the brain. , 1984, Science.

[100]  B. Yankner,et al.  Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[101]  R. Katzman.,et al.  Alzheimer Disease: Basic and Clinical Advances , 1991, Journal of the American Geriatrics Society.

[102]  R Luft,et al.  The development of mitochondrial medicine. , 1995, Biochimica et biophysica acta.

[103]  A. Guterman,et al.  Neurological Sequelae of Boxing , 1987, Sports medicine.

[104]  D. Kerr,et al.  BRAIN-ALUMINIUM CONCENTRATION IN DIALYSIS ENCEPHALOPATHY , 1978, The Lancet.

[105]  R. Tyrrell,et al.  Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. , 1991, Cancer research.

[106]  D. Selkoe,et al.  Amyloid protein and Alzheimer's disease. , 1991, Scientific American.

[107]  J. Sulston,et al.  The embryonic cell lineage of the nematode Caenorhabditis elegans. , 1983, Developmental biology.

[108]  J. Rogers,et al.  Anti‐inflammatory agents as a therapeutic approach to Alzheimer's disease , 1992, Neurology.

[109]  R. Salgia,et al.  Degradation and regurgitation of extracellular proteins by cultured mouse peritoneal macrophages and baby hamster kidney fibroblasts. Kinetic evidence that the transfer of proteins to lysosomes is not irreversible. , 1987, The Journal of biological chemistry.

[110]  W. D. Kaehny,et al.  The dialysis encephalopathy syndrome. Possible aluminum intoxication. , 1976, The New England journal of medicine.

[111]  Yasuo Ihara,et al.  Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments , 1993, Neuron.

[112]  M. Swash,et al.  Neurofibrillary neuronal degeneration in dialysis dementia: a feature of aluminum toxicity. , 1987, Clinical neuropathology.

[113]  E. Stopa,et al.  Basic fibroblast growth factor in Alzheimer's disease. , 1990, Biochemical and biophysical research communications.

[114]  H. Häfner Epidemiology of Alzheimer’s disease , 1990 .

[115]  G. Drewes,et al.  Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro , 1992, The Journal of cell biology.

[116]  B. L. Walker Maternal diet and brain fatty acids in young rats , 1967, Lipids.

[117]  P. O. Ganrot Metabolism and possible health effects of aluminum. , 1986, Environmental health perspectives.

[118]  P. Lansbury,et al.  The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.

[119]  B. Hyman,et al.  Alzheimer's mutation , 1991, Nature.

[120]  A. Himmler Structure of the bovine tau gene: alternatively spliced transcripts generate a protein family , 1989, Molecular and cellular biology.

[121]  M. Kirschner,et al.  Tau protein binds to microtubules through a flexible array of distributed weak sites , 1991, The Journal of cell biology.

[122]  D. Price,et al.  Age‐Dependent Impairment of Mitochondrial Function in Primate Brain , 1993, Journal of neurochemistry.

[123]  S. Little,et al.  Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. , 1991, Brain research. Molecular brain research.

[124]  D. Harman Aging: Prospects for further increases in the functional life span , 1994, AGE.

[125]  A. Tappel,et al.  Measurement and spectral characteristics of fluorescent pigments in tissues of rats as a function of dietary polyunsaturated fats and vitamin E. , 1973, The Journal of nutrition.

[126]  Hans Lassmann,et al.  Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ , 2004, Acta Neuropathologica.

[127]  E. Stadtman Oxidation of proteins by mixed-function oxidation systems: implication in protein turnover, ageing and neutrophil function , 1986 .

[128]  L. Wolfson,et al.  Clinico‐pathologic studies in dementia , 1988, Neurology.

[129]  H. Brewer,et al.  Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments , 1994, Nature.

[130]  D. Sherrard Aluminum--much ado about something. , 1991, The New England journal of medicine.

[131]  J. A. V Pritchard,et al.  CANCER DETECTION , 1976, The Lancet.

[132]  W. D. de Grip,et al.  Alzheimer's disease and cellular aging: membrane-related events as clues to primary mechanisms. , 1991, Gerontology.

[133]  C. Cotman,et al.  Lipid composition of synaptic plasma membranes isolated from rat brain by zonal centrifugation. , 1969, Biochemistry.

[134]  R. Nixon,et al.  Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[135]  S. Cadenas,et al.  Low mitochondrial free radical production per unit O2 consumption can explain the simultaneous presence of high longevity and high aerobic metabolic rate in birds. , 1994, Free radical research.

[136]  P. Fraser,et al.  An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar aβ-amyloid in rat brain , 1994, Neuron.

[137]  Y. Tamai,et al.  Lipid composition of nerve cell perikarya , 1971 .

[138]  C. W. Scott,et al.  Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[139]  B. Hyman,et al.  Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease. , 1994, The American journal of pathology.

[140]  C. W. Adams,et al.  The cerebral vasculature in dementia pugilistica. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[141]  E. Masliah,et al.  Protein kinase C alteration is an early biochemical marker in Alzheimer's disease , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[142]  H. Steller Mechanisms and genes of cellular suicide , 1995, Science.

[143]  D. Harman Free radical involvement in aging. Pathophysiology and therapeutic implications. , 1993, Drugs & aging.

[144]  P. Cohen,et al.  p42 map kinase phosphorylation sites in microtubule‐associated protein tau are dephosphorylated by protein phosphatase 2A1 Implications for Alzheimer's disease , 1992, FEBS letters.

[145]  Z. Oltvai,et al.  Checkpoints of dueling dimers foil death wishes , 1994, Cell.

[146]  J. H. Stekhoven,et al.  Exogenous aluminum accumulates in the lysosomes of cultured rat cortical neurons , 1990, Neuroscience Letters.

[147]  J. Parks,et al.  Abnormalities of the electron transport chain in idiopathic parkinson's disease , 1989, Annals of neurology.

[148]  P. Starke-Reed,et al.  Protein oxidation and proteolysis during aging and oxidative stress. , 1989, Archives of biochemistry and biophysics.

[149]  H. Wiśniewski,et al.  An Experimental Approach to the Morphogenesis of Neurofibrillary Degeneration and the Argyrophilic Plaque , 2008 .

[150]  D. Selkoe,et al.  Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.

[151]  J. Kimura,et al.  Immunocytochemical characterization of glial fibrillary tangles in Alzheimer's disease brain. , 1995, The American journal of pathology.

[152]  W. Lukiw,et al.  WOULD DECREASED ALUMINIUM INGESTION REDUCED THE INCIDENCE OF ALZHEIMER'S DISEASE ? , 1991 .

[153]  B. Crain,et al.  Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. , 1993, Genomics.

[154]  B. Regland,et al.  The role of amyloid β-protein in Alzheimer's disease , 1992, The Lancet.

[155]  J. Goldman,et al.  Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[156]  H. Wiśniewski,et al.  Neuropathology of the Aging Brain and Dementia of the Alzheimer Type , 1985 .

[157]  V. Hachinski,et al.  A NEW DEFINITION OF ALZHEIMER'S DISEASE: A HIPPOCAMPAL DEMENTIA , 1985, The Lancet.

[158]  R. S. Sohal,et al.  Hydrogen peroxide release by mitochondria increases during aging , 1991, Mechanisms of Ageing and Development.

[159]  S. Yen,et al.  Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments , 1992, Brain Research.

[160]  R. Dean A mechanism for accelerated degradation of intracellular proteins after limited damage by free radicals , 1987, FEBS letters.

[161]  R. Katzman.,et al.  Alzheimer's disease. , 1986, The New England journal of medicine.

[162]  T. Arendt,et al.  Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in alzheimer's disease , 1985, Neuroscience.

[163]  J. Blass,et al.  Systemic manifestations of Alzheimer’s disease , 1988, AGE.

[164]  D. Harman Free radical theory of aging: Consequences of mitochondrial aging , 1983, AGE.

[165]  J. Cooper,et al.  Mitochondrial myopathies: Clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA , 1989, Annals of neurology.

[166]  J. Nalbantoglu,et al.  Genetic Factors in Alzheimer's Disease , 1990, Journal of the American Geriatrics Society.

[167]  J. Miquel,et al.  Is cell aging caused by respiration-dependent injury to the mitochondrial genome? , 1982, Gerontology.

[168]  B. Strooper,et al.  α2-macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease , 1993, Neurobiology of Aging.

[169]  C. Marsden,et al.  Mitochondrial Complex I Deficiency in Parkinson's Disease , 1990, Lancet.

[170]  S. Orrenius,et al.  The role of Ca2+ in cell killing. , 1990, Chemical research in toxicology.

[171]  R. Nixon,et al.  The Lysosomal System in Neurons , 1992 .

[172]  R. Nixon,et al.  Free radicals, proteolysis, and the degeneration of neurons in alzheimer disease: How essential is the β-amyloid link? , 1994, Neurobiology of Aging.

[173]  M. Paula-Barbosa,et al.  ALZHEIMER'S DISEASE: PAIRED HELICAL FILAMENTS AND CYTOMEMBRANES , 1987, Neuropathology and applied neurobiology.

[174]  D. Harman,et al.  Free Radical Theory of Aging: Effect of Age, Sex and Dietary Precursors on Rat‐Brain Docosahexanoic Acid † , 1977, Journal of the American Geriatrics Society.

[175]  P. Lansbury,et al.  Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[176]  J. M. Blumberg,et al.  AN ELECTRON MICROSCOPIC STUDY OF DYSTROPHIC AXONS IN THE GRACILE AND CUNEATE NUCLEI OF VITAMIN E‐DEFICIENT RATS , 1964, Journal of neuropathology and experimental neurology.

[177]  D. Hegner,et al.  Do mitochondria produce oxygen radicals in vivo? , 1978, European journal of biochemistry.

[178]  C Oliver,et al.  Down's Syndrome and Alzheimer's disease: a review , 1986, Psychological Medicine.

[179]  R. DeTeresa,et al.  Some morphometric aspects of the brain in senile dementia of the alzheimer type , 1981, Annals of neurology.

[180]  L. Packer,et al.  Surface localization of sites of reduction of nitroxide spin-labeled molecules in mitochondria. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[181]  D. Brems,et al.  Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. , 1994, Molecular pharmacology.

[182]  D. Selkoe,et al.  Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. , 1992, Science.

[183]  O. Elroy-Stein,et al.  Overproduction of human Cu/Zn‐superoxide dismutase in transfected cells: extenuation of paraquat‐mediated cytotoxicity and enhancement of lipid peroxidation. , 1986, The EMBO journal.

[184]  R. Martins,et al.  Increased Cerebral Glucose‐6‐Phosphate Dehydrogenase Activity in Alzheimer's Disease May Reflect Oxidative Stress , 1986, Journal of neurochemistry.

[185]  R. A. Crowther,et al.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease , 1989, Neuron.

[186]  C. Masters,et al.  The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer's disease. , 1981, Brain : a journal of neurology.

[187]  S. Prusiner,et al.  Etiology and pathogenesis of prion diseases. , 1995, The American journal of pathology.

[188]  A. Harding Neurological disease and mitochondrial genes , 1991, Trends in Neurosciences.

[189]  D. Wallace,et al.  Heart disease and mitochondrial DNA mutations. , 1992, Heart disease and stroke : a journal for primary care physicians.

[190]  J. Lowe,et al.  Protein processing in lysosomes: the new therapeutic target in neurodegenerative disease , 1992, The Lancet.

[191]  K. Yoshikawa,et al.  Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor , 1992, Nature.

[192]  J. Merrill,et al.  Interactions of the nervous and immune systems in development, normal brain homeostasis, and disease 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[193]  K. Boje,et al.  Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death , 1992, Brain Research.

[194]  P. Lebon,et al.  Interferon-γ and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions , 1988, Journal of the Neurological Sciences.

[195]  D. Selkoe,et al.  Microinjection of synthetic amyloid beta-protein in monkey cerebral cortex fails to produce acute neurotoxicity. , 1993, The American journal of pathology.

[196]  D. Selkoe,et al.  Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments , 1992, Nature.

[197]  M. Beal,et al.  An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[198]  J. Growdon,et al.  Evidence for a membrane defect in Alzheimer disease brain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[199]  K. Beyreuther,et al.  Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. , 1992, The Journal of biological chemistry.

[200]  R. Tanzi,et al.  Modulation of A beta adhesiveness and secretase site cleavage by zinc. , 1994, The Journal of biological chemistry.

[201]  B. Hyman,et al.  The Lack of Accumulation of Senile Plaques or Amyloid Burden in Alzheimer's Disease Suggests a Dynamic Balance Between Amyloid Deposition and Resolution , 1993, Journal of neuropathology and experimental neurology.

[202]  M. Kirschner,et al.  Phosphorylation of microtubule‐associated protein tau: identification of the site for Ca2(+)‐calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles. , 1990, The EMBO journal.

[203]  S. L'Hernault,et al.  Mutation of a putative sperm membrane protein in Caenorhabditis elegans prevents sperm differentiation but not its associated meiotic divisions , 1992, The Journal of cell biology.

[204]  S. Estus,et al.  Production of the Alzheimer amyloid beta protein by normal proteolytic processing. , 1992, Science.

[205]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[206]  B. Ghetti,et al.  Alzheimer patients: preamyloid deposits are more widely distributed than senile plaques throughout the central nervous system , 1989, Neuroscience Letters.

[207]  D. Harman Free radical theory of aging. , 1992, Triangle; the Sandoz journal of medical science.

[208]  R. Weindruch,et al.  Multiple mitochondrial DNA deletions associated with age in skeletal muscle of rhesus monkeys. , 1993, Journal of gerontology.

[209]  M. Crawford,et al.  Nutritional influences in the evolution of mammalian brain. In: lipids, malnutrition & the developing brain. , 1971, Ciba Foundation symposium.

[210]  K. Davies Protein damage and degradation by oxygen radicals. I. general aspects. , 1987, The Journal of biological chemistry.

[211]  J. Ávila,et al.  Tau factor polymers are similar to paired helical filaments of Alzheimer's disease , 1988, FEBS letters.

[212]  Furnass Sb Seminal vitamin B-12 and sterility. , 1963 .

[213]  R. Nixon,et al.  Aluminum salts induce the accumulation of neurofilaments in perikarya of NB2a/dl neuroblastoma , 1989, Brain Research.

[214]  P. Lansbury,et al.  Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.

[215]  O. Elroy-Stein,et al.  Impaired neurotransmitter uptake in PC12 cells overexpressing human Cu/Zn-superoxide dimutase-implication for gene dosage effects in down syndrome , 1988, Cell.

[216]  G. Cole,et al.  Vitamin E protects nerve cells from amyloid βprotein toxicity , 1992 .

[217]  Yves Agid,et al.  Parkinson's disease: pathophysiology , 1991, The Lancet.

[218]  D. Allsop,et al.  The occult aftermath of boxing. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[219]  S. Yorifuji,et al.  Treatment of Kearns‐Sayre syndrome with coenzyme Q10 , 1986, Neurology.

[220]  Margaret A. Pericak-Vance,et al.  Hypothesis: Microtubule Instability and Paired Helical Filament Formation in the Alzheimer Disease Brain Are Related to Apolipoprotein E Genotype , 1994, Experimental Neurology.

[221]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[222]  C. Filley,et al.  Cytochrome oxidase deficiency in Alzheimer's disease , 1990, Neurology.

[223]  R. Bucala,et al.  Advanced glycation end products contribute to amyloidosis in Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[224]  R. Friede The relation of the formation of lipofuscin to the distribution of oxidative enzymes in the human brain , 2004, Acta Neuropathologica.

[225]  H. Wiśniewski,et al.  Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains. , 1992, Biochemical and biophysical research communications.

[226]  M. Tabaton,et al.  Subcellular localization of amyloid precursor protein in senile plaques of Alzheimer's disease. , 1992, The American journal of pathology.

[227]  Bradley T. Hyman,et al.  Distribution of Alzheimer‐type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease , 1992, Neurology.

[228]  W. Lukiw,et al.  Would decreased aluminum ingestion reduce the incidence of Alzheimer's disease? , 1991, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[229]  R. S. Sohal,et al.  Comparison of mitochondrial pro-oxidant generation and anti-oxidant defenses between rat and pigeon: possible basis of variation in longevity and metabolic potential , 1993, Mechanisms of Ageing and Development.

[230]  A. Cataldo,et al.  Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[231]  D. Turnbull,et al.  Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease , 1991, Journal of the Neurological Sciences.

[232]  B. Bowerman Determinants of blastomere identity in the early C. elegans embryo , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[233]  Bradley T. Hyman,et al.  Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.

[234]  H. Braak,et al.  Morphology of the cerebral cortex in relation to Alzheimer’s dementia , 1989 .

[235]  E. Stadtman,et al.  Covalent modification reactions are marking steps in protein turnover. , 1990, Biochemistry.

[236]  M. Goedert,et al.  Risky apolipoprotein in brain , 1994, Nature.

[237]  T. Iwatsubo,et al.  Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43) , 1994, Neuron.

[238]  D. Harman Free Radical Involvement in Aging , 1993 .

[239]  D. Graham,et al.  βA4 amyloid protein deposition in brain after head trauma , 1991, The Lancet.

[240]  W. D. Ehmann,et al.  Laser microprobe analysis of brain aluminum in Alzheimer' disease , 1993, Annals of neurology.

[241]  D. Harman,et al.  Free radical theory of aging: Beneficial effect of adding antioxidants to the maternal mouse diet on life span of offspring; possible explanation of the sex difference in longevity , 1979, AGE.

[242]  G. Perry,et al.  Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. , 1994, The American journal of pathology.

[243]  L. Higgins,et al.  Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for beta-APP751. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[244]  B. I. Roots Neurofilament accumulation induced in synapses by leupeptin. , 1983, Science.

[245]  M. Sagai,et al.  Age-related changes in lipid peroxidation as measured by ethane, ethylene, butane and pentane in respired gases of rats. , 1980, Life sciences.

[246]  E. Stadtman,et al.  Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. , 1990, Free radical biology & medicine.

[247]  C. Behl,et al.  Amyloid β peptide induces necrosis rather than apoptosis , 1994, Brain Research.

[248]  R. S. Sohal,et al.  Relationship between mitochondrial superoxide and hydrogen peroxide production and longevity of mammalian species. , 1993, Free radical biology & medicine.

[249]  C Osmond,et al.  GEOGRAPHICAL RELATION BETWEEN ALZHEIMER'S DISEASE AND ALUMINIUM IN DRINKING WATER , 1989, The Lancet.

[250]  N. Cairns,et al.  Tau proteins of alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms , 1992, Neuron.

[251]  E. Stadtman,et al.  Metal-catalyzed oxidation of proteins. Physiological consequences. , 1991, The Journal of biological chemistry.

[252]  S. Prusiner,et al.  Prions and neurodegenerative diseases. , 1987, The New England journal of medicine.

[253]  C. Thompson,et al.  Apoptosis in the pathogenesis and treatment of disease , 1995, Science.

[254]  R. Gregg,et al.  Abnormal in vivo metabolism of apolipoprotein E4 in humans. , 1986, The Journal of clinical investigation.

[255]  L. Lovat,et al.  Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[256]  R. Terry,et al.  ULTRASTRUCTURAL STUDIES IN ALZHEIMER'S PRESENILE DEMENTIA. , 1964, The American journal of pathology.

[257]  S. Orrenius,et al.  Cytoskeletal alterations in human platelets exposed to oxidative stress are mediated by oxidative and Ca2+-dependent mechanisms. , 1989, Archives of biochemistry and biophysics.

[258]  B. Hyman,et al.  Do defecs in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? , 1993, Trends in Neurosciences.

[259]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[260]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[261]  R. Lyman,et al.  Evidence for nonessentiality of linolenic acid in the diet of the rat. , 1971, The Journal of nutrition.

[262]  S. DeKosky,et al.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.

[263]  Khadija Iqbal,et al.  Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. , 1993, Archives of biochemistry and biophysics.

[264]  D. Harman,et al.  Lipofuscin and ceroid formation: the cellular recycling system. , 1989, Advances in experimental medicine and biology.

[265]  D. Mann,et al.  Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down Syndrome , 1995, Annals of neurology.

[266]  D. Mann,et al.  The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome , 1989, Journal of the Neurological Sciences.

[267]  A. Davison,et al.  Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? , 1990, Free radical biology & medicine.